What's breaking now, across thousands of outlets.
AstraZeneca will “redeploy resources” through a new restructuring program. Meanwhile, Alnylam shares sold off on fears surrounding a top drug and investors rewarded Regeneron for a record quarter.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
British International Investment (BII), the United Kingdom’s development finance institution, plans to invest about £2.25 billion ($3 billion) in Africa’s frontier markets and least-developed…
The concentration of activity underscores how quickly the issuance window opened after a subdued first quarter, according to Grant Thornton Bharat’s report, India IPO Market review
Any deal for EchoStar's wireless unit may require consent from AT&T and T-Mobile, whose networks Boost Mobile leases
Citi's head of equity-trading strategy acknowledged his call on AI-focused stocks has not worked as growth names lag
Three ancient wooden boats unearthed in Beijing and dating back about 1,800 years offer new evidence of shipbuilding technology and cultural exchanges between ancient China and the rest of the world…
